The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models

Epilepsy is one of the most common neurological conditions. Yearly, five million people are diagnosed with epileptic-related disorders. The neuroprotective and therapeutic effect of (endo)cannabinoid compounds has been extensively investigated in several models of epilepsy. Therefore, the study of s...

Full description

Bibliographic Details
Main Authors: Jon Egaña-Huguet, Edgar Soria-Gómez, Pedro Grandes
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/24/13231
_version_ 1797503935315968000
author Jon Egaña-Huguet
Edgar Soria-Gómez
Pedro Grandes
author_facet Jon Egaña-Huguet
Edgar Soria-Gómez
Pedro Grandes
author_sort Jon Egaña-Huguet
collection DOAJ
description Epilepsy is one of the most common neurological conditions. Yearly, five million people are diagnosed with epileptic-related disorders. The neuroprotective and therapeutic effect of (endo)cannabinoid compounds has been extensively investigated in several models of epilepsy. Therefore, the study of specific cell-type-dependent mechanisms underlying cannabinoid effects is crucial to understanding epileptic disorders. It is estimated that about 100 billion neurons and a roughly equal number of glial cells co-exist in the human brain. The glial population is in charge of neuronal viability, and therefore, their participation in brain pathophysiology is crucial. Furthermore, glial malfunctioning occurs in a wide range of neurological disorders. However, little is known about the impact of the endocannabinoid system (ECS) regulation over glial cells, even less in pathological conditions such as epilepsy. In this review, we aim to compile the existing knowledge on the role of the ECS in different cell types, with a particular emphasis on glial cells and their impact on epilepsy. Thus, we propose that glial cells could be a novel target for cannabinoid agents for treating the etiology of epilepsy and managing seizure-like disorders.
first_indexed 2024-03-10T03:57:28Z
format Article
id doaj.art-6cbb497e4aea48ae8dd4000b0fc838e6
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T03:57:28Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6cbb497e4aea48ae8dd4000b0fc838e62023-11-23T08:43:17ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0122241323110.3390/ijms222413231The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal ModelsJon Egaña-Huguet0Edgar Soria-Gómez1Pedro Grandes2Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940 Leioa, SpainDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940 Leioa, SpainDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940 Leioa, SpainEpilepsy is one of the most common neurological conditions. Yearly, five million people are diagnosed with epileptic-related disorders. The neuroprotective and therapeutic effect of (endo)cannabinoid compounds has been extensively investigated in several models of epilepsy. Therefore, the study of specific cell-type-dependent mechanisms underlying cannabinoid effects is crucial to understanding epileptic disorders. It is estimated that about 100 billion neurons and a roughly equal number of glial cells co-exist in the human brain. The glial population is in charge of neuronal viability, and therefore, their participation in brain pathophysiology is crucial. Furthermore, glial malfunctioning occurs in a wide range of neurological disorders. However, little is known about the impact of the endocannabinoid system (ECS) regulation over glial cells, even less in pathological conditions such as epilepsy. In this review, we aim to compile the existing knowledge on the role of the ECS in different cell types, with a particular emphasis on glial cells and their impact on epilepsy. Thus, we propose that glial cells could be a novel target for cannabinoid agents for treating the etiology of epilepsy and managing seizure-like disorders.https://www.mdpi.com/1422-0067/22/24/13231endocannabinoid systemglial cellsepilepsyneuroinflammation
spellingShingle Jon Egaña-Huguet
Edgar Soria-Gómez
Pedro Grandes
The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
International Journal of Molecular Sciences
endocannabinoid system
glial cells
epilepsy
neuroinflammation
title The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
title_full The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
title_fullStr The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
title_full_unstemmed The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
title_short The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
title_sort endocannabinoid system in glial cells and their profitable interactions to treat epilepsy evidence from animal models
topic endocannabinoid system
glial cells
epilepsy
neuroinflammation
url https://www.mdpi.com/1422-0067/22/24/13231
work_keys_str_mv AT joneganahuguet theendocannabinoidsysteminglialcellsandtheirprofitableinteractionstotreatepilepsyevidencefromanimalmodels
AT edgarsoriagomez theendocannabinoidsysteminglialcellsandtheirprofitableinteractionstotreatepilepsyevidencefromanimalmodels
AT pedrograndes theendocannabinoidsysteminglialcellsandtheirprofitableinteractionstotreatepilepsyevidencefromanimalmodels
AT joneganahuguet endocannabinoidsysteminglialcellsandtheirprofitableinteractionstotreatepilepsyevidencefromanimalmodels
AT edgarsoriagomez endocannabinoidsysteminglialcellsandtheirprofitableinteractionstotreatepilepsyevidencefromanimalmodels
AT pedrograndes endocannabinoidsysteminglialcellsandtheirprofitableinteractionstotreatepilepsyevidencefromanimalmodels